Liver cancer screening uses ultrasound and AFP biomarker tests, with CT or MRI for further evaluation if abnormalities are found. Staging assesses cancer's size, spread, and involvement of blood ...

The US FDA has approved Wako Diagnostics’s new LBA AFP-L3 test system. It is intended for the risk assessment of developing hepatocellular carcinoma (HCC), liver cancer in patients with chronic liver ...

Cirrhosis and liver cancer are two of the world’s leading causes of illness and death, but they typically creep up quietly. Most people with liver disease are symptom-free until complications like ...

Researchers have recently created a blood test that can detect liver disease years before symptoms ever develop, helping pave the way for the diagnosis of diseases such as cirrhosis and liver cancer ...

Cancer of the liver, seen in a radial cross-section abdominal scan. (Photo by: BSIP/Universal Images Group via Getty Images) The number of new liver cancer cases will nearly double in the next 25 ...